VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 356 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2016. The put-call ratio across all filers is 1.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $1,075,000 | -72.4% | 51,725 | -81.0% | 1.51% | -65.4% |
Q3 2017 | $3,900,000 | -17.2% | 272,148 | 0.0% | 4.36% | -18.4% |
Q2 2017 | $4,708,000 | +56.8% | 272,148 | 0.0% | 5.34% | +45.3% |
Q1 2017 | $3,002,000 | -24.0% | 272,148 | 0.0% | 3.68% | -29.6% |
Q4 2016 | $3,952,000 | -46.1% | 272,148 | -8.9% | 5.22% | -46.2% |
Q3 2016 | $7,332,000 | +18.4% | 298,648 | -2.9% | 9.70% | +0.5% |
Q2 2016 | $6,192,000 | -23.4% | 307,458 | 0.0% | 9.65% | -15.8% |
Q1 2016 | $8,086,000 | -64.2% | 307,458 | +38.3% | 11.46% | -55.4% |
Q4 2015 | $22,595,000 | -34.1% | 222,282 | +15.7% | 25.68% | -5.5% |
Q3 2015 | $34,272,000 | +9.4% | 192,130 | +36.2% | 27.18% | +12.5% |
Q2 2015 | $31,328,000 | +11.8% | 141,020 | 0.0% | 24.16% | +9.3% |
Q1 2015 | $28,009,000 | -25.6% | 141,020 | -46.4% | 22.10% | -17.1% |
Q4 2014 | $37,626,000 | -16.0% | 262,920 | -23.0% | 26.64% | -11.5% |
Q3 2014 | $44,807,000 | +6.7% | 341,518 | +2.5% | 30.12% | +11.2% |
Q2 2014 | $42,008,000 | +14.7% | 333,081 | +19.9% | 27.09% | +19.9% |
Q1 2014 | $36,624,000 | +26.2% | 277,812 | +12.4% | 22.59% | +24.9% |
Q4 2013 | $29,012,000 | +12.5% | 247,121 | 0.0% | 18.09% | +1.8% |
Q3 2013 | $25,782,000 | +21.3% | 247,121 | +0.1% | 17.78% | +10.1% |
Q2 2013 | $21,249,000 | – | 246,856 | – | 16.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |